Literature DB >> 34245267

Outcomes of Standard and Intensified Dosing of Ustekinumab for Chronic Pouch Disorders.

Rahul S Dalal1, Sanchit Gupta1, Hannah Goodrick1, Jennifer Mitri1, Jessica R Allegretti1.   

Abstract

Entities:  

Keywords:  Crohn’s disease; cuffitis; ileal pouch; inflammatory bowel disease; pouchitis; ulcerative colitis

Mesh：

Substances：

Year:  2022        PMID： 34245267      PMCID： PMC8730681          DOI： 10.1093/ibd/izab156

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   7.290


× No keyword cloud information.
  10 in total

1.  The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort.

Authors:  Laura E Targownik; Harminder Singh; Zoann Nugent; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2012-05-22       Impact factor: 10.864

2.  Recycling of Precolectomy Anti-Tumor Necrosis Factor Agents in Chronic Pouch Inflammation Is Associated With Treatment Failure.

Authors:  Maia Kayal; Thomas Lambin; Michael Plietz; Anam Rizvi; Marlana Radcliffe; Sergey Khaitov; Patricia Sylla; Alexander J Greenstein; Jean Frederic Colombel; Marla C Dubinsky; Ryan C Ungaro
Journal:  Clin Gastroenterol Hepatol       Date:  2020-07-12       Impact factor: 11.382

3.  Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.

Authors:  Mathilde Huguet; Bruno Pereira; Marion Goutte; Félix Goutorbe; Anne Dubois; Gilles Bommelaer; Anthony Buisson
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

4.  Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index.

Authors:  W J Sandborn; W J Tremaine; K P Batts; J H Pemberton; S F Phillips
Journal:  Mayo Clin Proc       Date:  1994-05       Impact factor: 7.616

5.  Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.

Authors:  Constance Chapuis-Biron; Julien Kirchgesner; Benjamin Pariente; Yoram Bouhnik; Aurélien Amiot; Stéphanie Viennot; Mélanie Serrero; Mathurin Fumery; Matthieu Allez; Laurent Siproudhis; Anthony Buisson; Guillaume Pineton de Chambrun; Vered Abitbol; Stéphane Nancey; Ludovic Caillo; Laurianne Plastaras; Guillaume Savoye; Elise Chanteloup; Marion Simon; Nina Dib; Sylvie Rajca; Morgane Amil; Anne-Laure Parmentier; Laurent Peyrin-Biroulet; Lucine Vuitton
Journal:  Am J Gastroenterol       Date:  2020-11       Impact factor: 10.864

6.  Inflammatory Pouch Conditions Are Common After Ileal Pouch Anal Anastomosis in Ulcerative Colitis Patients.

Authors:  Maia Kayal; Michael Plietz; Anam Rizvi; Marlana Radcliffe; Alexa Riggs; Clara Yzet; Emily Tixier; Parth Trivedi; Ryan C Ungaro; Sergey Khaitov; Patricia Sylla; Alexander Greenstein; Jean Frederic Colombel; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2020-06-18       Impact factor: 5.325

7.  Male Gender Is Associated with a High Risk for Chronic Antibiotic-Refractory Pouchitis and Ileal Pouch Anastomotic Sinus.

Authors:  Xian-Rui Wu; Jean Ashburn; Feza H Remzi; Yi Li; Hagar Fass; Bo Shen
Journal:  J Gastrointest Surg       Date:  2015-10-07       Impact factor: 3.452

8.  Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort.

Authors:  Kimberly N Weaver; Martin Gregory; Gaurav Syal; Patrick Hoversten; Stephen Bradley Hicks; Devin Patel; George Christophi; Poonam Beniwal-Patel; Kim L Isaacs; Laura Raffals; Parakkal Deepak; Hans H Herfarth; Edward L Barnes
Journal:  Inflamm Bowel Dis       Date:  2019-03-14       Impact factor: 5.325

9.  Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis.

Authors:  Jacob E Ollech; David T Rubin; Laura Glick; Roni Weisshof; Katia El Jurdi; Amanda Israel; Noa Krugliak Cleveland; Neil Hyman; Atsushi Sakuraba; Joel Pekow; Russell D Cohen; Sushila R Dalal
Journal:  Dig Dis Sci       Date:  2019-06-11       Impact factor: 3.199

10.  Predictors of Ustekinumab Failure in Crohn's Disease After Dose Intensification.

Authors:  Rahul S Dalal; Cheikh Njie; Jenna Marcus; Sanchit Gupta; Jessica R Allegretti
Journal:  Inflamm Bowel Dis       Date:  2021-07-27       Impact factor: 5.325
  10 in total
  2 in total

Review 1.  Targeting IL12/23 in ulcerative colitis: update on the role of ustekinumab.

Authors:  Daniela Pugliese; Giuseppe Privitera; Marcello Fiorani; Laura Parisio; Valentin Calvez; Alfredo Papa; Antonio Gasbarrini; Alessandro Armuzzi
Journal:  Therap Adv Gastroenterol       Date:  2022-06-13       Impact factor: 4.802

Review 2.  Medical management of chronic pouch inflammation.

Authors:  Maia Kayal; Marla C Dubinsky
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.